Clinical Trials Logo

Clinical Trial Summary

Evaluation of the safety and efficacy of fractional radiofrequency for the treatment of moderate to severe acne vulgaris.


Clinical Trial Description

This is an interventional, multicenter, open (self-controlled) trial to evaluate the safety and efficacy of fractional radiofrequency for the treatment of moderate to severe acne vulgaris. The study will evaluate up to 30 male or female participants requesting treatment for the reduction of moderate to severe acne vulgaris. The study will involve three treatments of fractional radiofrequency. Treatments will be randomized with combination antibiotic/ fractional radiofrequency therapy. The subject will act as their own control, where one side of the face (buccal area) will be treated, and the other will not be and will act as the control. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06315166
Study type Interventional
Source Pollogen
Contact Yuri Vinshtok, MD
Phone +972-52-731-1222
Email Yuri_v@pollogen.com
Status Recruiting
Phase N/A
Start date April 10, 2024
Completion date December 2025

See also
  Status Clinical Trial Phase
Recruiting NCT06378983 - Clinical Trial of Microneedle Radiofrequency Combined With Oral Isotretinoin in Moderate to Severe Acne N/A
Completed NCT04163263 - Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of Repeat Topical Application of BOS-356 in Subjects With Moderate to Severe Acne Vulgaris Phase 1